⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8266084 | 1.00 | — | — | |
| SCHEMBL19202494 | 1.00 | — | — | |
| SCHEMBL10296559 | 0.74 | — | — | |
| SCHEMBL9830453 | 0.69 | — | — | |
| SCHEMBL12826309 | 0.67 | — | — | |
| SCHEMBL14084913 | 0.67 | — | — | |
| SCHEMBL18322504 | 0.67 | — | — | |
| SCHEMBL2754686 | 0.67 | — | — | |
| SCHEMBL21535783 | 0.67 | — | — | |
| SCHEMBL9832222 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-61118366-A | — | — | None | — | — | JP | disclosed |
| EP-4103566-B1 | FUSED PYRIMIDINE COMPOUNDS AS KCC2 MODULATORS | ASTRAZENECA AB (SE) | 2023-10-04 | — | — | EP | disclosed |
| EP-4011877-A2 | METHOD OF TREATING ELEVATED PLASMA CHOLESTEROL | Institut de Cardiologie de Montréal (CA) | 2022-06-15 | — | — | EP | disclosed |
| WO-2022026892-A1 | PIPERIDIN-1- YL-N-PYRYDI NE-3-YL-2-OXOACET AM IDE DERIVATIVES USEFUL FOR THE TREATMENT OF MTAP-DEFICIENT AND/OR MT A-ACCUMULATING CANCERS | TANGO THERAPEUTICS, INC. (US) | 2022-02-03 | — | — | WO | disclosed |
| EP-3798214-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | Vertex Pharmaceuticals Incorporated (US) | 2021-03-31 | — | — | EP | disclosed |
| EP-3186249-B1 | PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULPHUR CONTAINING SUBSTITUENTS | SYNGENTA PARTICIPATIONS AG (CH) | 2020-12-09 | — | — | EP | disclosed |
| EP-3294752-B1 | PEPTIDE TREATMENT FOR INFLAMMATION AND FIBROSIS | UNIV CALIFORNIA (US) | 2020-11-04 | — | — | EP | disclosed |
| US-10660789-B2 | 1,4-dihydropyridine derivatives with HSP modulating activity | RICHTER GEDEON NYRT. (HU) | 2020-05-26 | — | — | US | disclosed |
| US-10653749-B2 | Targeting GIV-GEF-GI signaling for treating diverse diseases | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-05-19 | — | — | US | disclosed |
| CN-110606822-A | 1,4-dihydropyridine derivatives having HSP modulating activity | 里克特吉迪翁公司 | 2019-12-24 | — | — | CN | disclosed |
| US-6383764-B1 | ADMINISTERING PEPTIDE OR FUNCTIONAL PEPTIDE ANALOG TO MAMMAL AND DETERMINING ABILITY OF COMPOUND TO CONTROL SEIZURES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2002-05-07 | — | — | US | disclosed |
| US-20020037533-A1 | Screening and therapeutic methods for promoting wakefulness and sleep | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-03-28 | — | — | US | disclosed |
| US-6348567-B1 | A PEPTIDE DERIVED FROM STREPTOKINASE; THERAPY FOR NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISEASES, AUTOIMMUNE DISEASES, PARKINSON'S/ALZHEIMER'S/HUNTINGTON'S DISEASES AND INFLAMMATORY DISEASES | CV MOLECULAR THERAPEUTICS INC. (CA) | 2002-02-19 | — | — | US | disclosed |
| EP-1171607-A1 | STREPTOKINASE FRAGMENTS AND THEIR USE FOR INHIBITING CELL DEATH | Rabkin, Simon W. (CA) | 2002-01-16 | — | — | EP | disclosed |
| WO-2000063384-A1 | STREPTOKINASE FRAGMENTS AND THEIR USE FOR INHIBITING CELL DEATH | RABKIN SIMON W (CA) | 2000-10-26 | — | — | WO | disclosed |
| EP-0157260-B1 | 4,7-DIHYDROPYRAZOLO(3,4-B)PYRIDINE DERIVATIVES | SHIONOGI & CO., LTD. (JP) | 1990-06-13 | — | — | EP | disclosed |
| EP-0362635-A1 | Use of nitro-phenyl-dihydropyridine amides as medicaments, compounds and processes for their preparation using intermediates | BAYER AG (DE) | 1990-04-11 | — | — | EP | disclosed |
| US-4873334-A | HYPOTENSIVE AGENTS, CORONARY VASODILATORS | SHIONOGI & CO., LTD. (JP) | 1989-10-10 | — | — | US | disclosed |
| JP-S61118366-A | INTERMEDIATE OF 2-METHYLDIHYDROPYRIDINE DERIVATIVE | FUJISAWA PHARMACEUT CO LTD | 1986-06-05 | — | — | JP | disclosed |
| EP-0157260-A1 | 4,7-Dihydropyrazolo(3,4-b)Pyridine derivatives | SHIONOGI & CO., LTD. (JP) | 1985-10-09 | — | — | EP | disclosed |